These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 25646108

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The roles of patents and research and development incentives in biopharmaceutical innovation.
    Grabowski HG, DiMasi JA, Long G.
    Health Aff (Millwood); 2015 Feb; 34(2):302-10. PubMed ID: 25646111
    [Abstract] [Full Text] [Related]

  • 5. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ.
    Arch Med Res; 2005 Feb; 36(6):697-705. PubMed ID: 16216651
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach.
    Rex JH, Outterson K.
    Lancet Infect Dis; 2016 Apr; 16(4):500-5. PubMed ID: 27036356
    [Abstract] [Full Text] [Related]

  • 8. Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.
    Deak D, Outterson K, Powers JH, Kesselheim AS.
    Ann Intern Med; 2016 Sep 06; 165(5):363-72. PubMed ID: 27239977
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Learning from our mistakes: using key opportunities to remove the perverse incentives that help drive antibiotic resistance.
    Edwards SE, Morel CM.
    Expert Rev Pharmacoecon Outcomes Res; 2019 Dec 06; 19(6):685-692. PubMed ID: 31847613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    Anderson M, Panteli D, Mossialos E.
    ; 2023 Dec 06. PubMed ID: 37582187
    [Abstract] [Full Text] [Related]

  • 17. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP.
    N Engl J Med; 2004 Aug 05; 351(6):523-6. PubMed ID: 15295041
    [No Abstract] [Full Text] [Related]

  • 18. Into the valley of death: research to innovation.
    Hudson J, Khazragui HF.
    Drug Discov Today; 2013 Jul 05; 18(13-14):610-3. PubMed ID: 23402848
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Will lower drug prices jeopardize drug research? A policy fact sheet.
    Light DW, Lexchin J.
    Am J Bioeth; 2004 Jul 05; 4(1):W1-4. PubMed ID: 15035915
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.